Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Otte

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Hellenic Journal of Nuclear Medicine|February 15, 2008
Hybrid imaging: which road to go?Andreas Otte
Hellenic Journal of Nuclear Medicine|April 9, 2008
Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin) treatment in follicular non-Hodgkin's lymphomaAndreas Otte
Deutsches Arzteblatt International|February 10, 2017
Music and NeurophysiologyAndreas Otte
Nuclear Medicine Communications|June 24, 2006
90Y-Ibritumomab tiuxetan: new drug, interesting concept, and encouraging in practiceAndreas Otte
MMW Fortschritte Der Medizin|May 17, 2017
Andreas Otte
Hellenic Journal of Nuclear Medicine|March 14, 2012
Neuroimaging in mild traumatic brain injury and M. Ravel's injuryAndreas Otte
Nuclear Medicine Communications|August 30, 2008
Does health economics have an impact on non-Hodgkin's lymphoma patients' options?Andreas Otte
Hellenic Journal of Nuclear Medicine|April 18, 2006
Inspiration-sleep-rest and nuclear medicineAndreas Otte
MMW Fortschritte Der Medizin|August 12, 2020
Andreas Otte
Hellenic Journal of Nuclear Medicine|April 23, 2011
The rationale of a longer life span and nuclear medicineAndreas Otte, Konrad Wink
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Hellenic Journal of Nuclear Medicine|February 15, 2008
Hybrid imaging: which road to go?Andreas Otte
Hellenic Journal of Nuclear Medicine|April 9, 2008
Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin) treatment in follicular non-Hodgkin's lymphomaAndreas Otte
Deutsches Arzteblatt International|February 10, 2017
Music and NeurophysiologyAndreas Otte
Nuclear Medicine Communications|June 24, 2006
90Y-Ibritumomab tiuxetan: new drug, interesting concept, and encouraging in practiceAndreas Otte
MMW Fortschritte Der Medizin|May 17, 2017
Andreas Otte
Hellenic Journal of Nuclear Medicine|March 14, 2012
Neuroimaging in mild traumatic brain injury and M. Ravel's injuryAndreas Otte
Nuclear Medicine Communications|August 30, 2008
Does health economics have an impact on non-Hodgkin's lymphoma patients' options?Andreas Otte
Hellenic Journal of Nuclear Medicine|April 18, 2006
Inspiration-sleep-rest and nuclear medicineAndreas Otte
MMW Fortschritte Der Medizin|August 12, 2020
Andreas Otte
Hellenic Journal of Nuclear Medicine|April 23, 2011
The rationale of a longer life span and nuclear medicineAndreas Otte, Konrad Wink
Pageof 9